Toll-like receptor 3 and Melanoma differentiation-associated protein 5 (TLR3 and MDA5)

Toll-like receptor 3 (TLR3) and Melanoma differentiation-associated protein 5 (MDA5) are key pattern recognition receptors that detect viral double-stranded RNA as part of the innate immune response. TLR3 is primarily located in endosomal membranes, recognizing dsRNA internalized into endosomes, and signals through the TRIF adaptor to trigger production of type I interferons and cytokines. MDA5 is a cytosolic RNA helicase that senses longer or unmodified dsRNA in the cytoplasm and signals through the mitochondrial antiviral-signaling protein (MAVS/IPS1) to induce a similar interferon response. Both receptors are central to antiviral defense, inflammation, and immunoregulation; their activation can lead to apoptosis, modulation of T and NK cell responses, and serve critical roles in controlling viral infections, mediating cancer immune adjuvant effects, and influencing autoimmune phenomena. Poly(I:C) is a canonical synthetic ligand used in experimental systems to activate both TLR3 and MDA5. Overactivation or dysregulation of these pathways may lead to tissue injury, excessive inflammation, or autoimmunity.

Other names

TLR3: Toll-like receptor 3MDA5: Melanoma differentiation-associated gene 5IFIH1 (interferon induced with helicase C domain 1)

Agonists (e.g., poly(I:C)): Bind to TLR3 in endosomes and MDA5 in the cytosol, mimicking viral dsRNA, triggering downstream signaling through TRIF (TLR3) or MAVS (MDA5), leading to type I IFN and pro-inflammatory cytokine production. Indirect anti-tumor and antiviral activity via immune system activation.